Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Reform Efforts Persisting, PBM Trade Association Sets Lobbying Record

Executive Summary

Infographic details who gave what to whom as all segments of the US healthcare industry gear up for the presidential election cycle.

You may also be interested in...



US Off-Patent Legislation Could Save Over $1bn In Ten Years

If passed, the two bills favoring generics and biosimilar developers would not only result in federal savings but would also lead to earlier market entry for off-patent drugs.

Time To Tip the Scales? Humira Biosimilars And The Limitations Of Competition In US Health Care

In year two, Humira biosimilar uptake – or the lack thereof – continues to build the case for policy reform to incentivize use of cheaper biologics in the outpatient setting.

Pharma Spent Record Amount on Lobbying in 2022

Our infographic breaks down the biggest contributors, recipients and legislative targets.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS149966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel